Stem cells are often seen as potential agents in the field of regenerative medicine. What are the realities and what should doctors expect? Dr. Marc Hedrick, president of San Diego-based Cytori Therapeutics, tells the Chicago Tribune's Bruce Japsen about commercialized treatments already being used, and even more on the horizon.
Real Uses for Stem Cells On the Horizon
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Stem cells are often seen as potential agents in the field of regenerative medicine. What are the realities and what should doctors expect? Dr. Marc Hedrick, president of San Diego-based Cytori Therapeutics, tells the Chicago Tribune's Bruce Japsen about commercialized treatments already being used, and even more on the horizon.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Second-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?